45 results
8-K
EX-10.1
YTEN
Yield10 Bioscience Inc
25 Aug 20
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
4:10pm
to directors, officers and employees of the Company, (y) one or more Investors may engage in hedging activities at various times during the period … that the Shares are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company
8-K
EX-10.1
YTEN
Yield10 Bioscience Inc
20 Nov 19
Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment Option
12:00am
, officers and employees of the Company, (y) one or more Investors may engage in hedging activities at various times during the period … are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company
8-K
EX-10.1
YTEN
Yield10 Bioscience Inc
4 Aug 14
Metabolix, Inc. Enters into Private Placement Agreement with Investors to Raise $25 Million in Equity Financing
12:00am
) one or more Investors may engage in hedging activities at various times during the period that the Securities are outstanding, including, without … limitation, during the periods that the value of the Underlying Shares deliverable with respect to Securities are being determined, and (z) such hedging
8-K
8frvf13
7 Oct 15
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
12:00am
424B3
41g v6yq5g84
18 Jul 23
Prospectus supplement
2:38pm
8-K
EX-10.1
5pwql w3wytly
15 Mar 19
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
9:25am
8-K
EX-10.1
5hxvw hrh
7 Oct 15
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
12:00am
8-K
EX-10.1
hx1fw
4 May 23
Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement
5:12pm
8-K
EX-4.1
3atkr
7 Oct 15
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
12:00am
8-K
EX-1.1
b0x uusvl0c
25 Aug 20
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
4:10pm
8-K
EX-1.1
zukjtmb
2 Feb 21
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
4:38pm